Search results
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 2 days agoSales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition from cheaper...
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Zacks via Yahoo Finance· 2 days agoShares of this drugmaker have returned -10% over the past month versus the Zacks S&P 500 composite's...
AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
Zacks via Yahoo Finance· 7 days agoAbbVie (ABBV) delivered earnings and revenue surprises of 2.21% and 2.65%, respectively, for the...
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
Motley Fool via Yahoo Finance· 7 days agoThose sales figures would be more than twice the drugs' totals last year. Those are just two of the...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 1 day agoLast year, major pharmaceutical companies heavily invested in R&D, with expenditure ranging from around 14% to 50% of their revenues. Some of the...
AbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up By Investing.com
Investing.com· 7 days agoAbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up
Better Dividend Stock: AbbVie or Johnson & Johnson?
Motley Fool via Yahoo Finance· 5 days agoLast year, the company earned approval for Epkinly, a new cancer medicine that could reach peak sales of $3 billion in the U.S. alone, according to some...
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition By Investing.com
Investing.com· 4 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
AbbVie Inc (ABBV) Q1 2024 Earnings: Adjusted EPS Tops Estimates Despite Revenue Challenges
GuruFocus.com via Yahoo Finance· 7 days agoOn April 26, 2024, AbbVie Inc (NYSE:ABBV) released its 8-K filing, detailing the financial outcomes...
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz· 7 days agoSales of the pharma giant's newer drugs are offsetting its Humira losses.